Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine
Vital Signs with Jacob Effron and Nikhil Krishnan
Navigating the Obesity Drug Supply Chain
This chapter explores the complexities of drug supply chains for obesity medications, highlighting improvements in accessibility due to manufacturers like Novo Nordisk. The discussion also addresses regional disparities, patient challenges in obtaining medications, and the need for better insurance coverage for obesity treatments.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
